-- 大塚製薬（東証：4768）の親会社株主に帰属する第1四半期の利益は、前年同期の145億円から15%増加し、167億円となった。 同社の1株当たり基本利益は、前年同期の38.22円から44.01円に増加した。これは、木曜日に東京証券取引所に提出された書類で明らかになった。 3月31日までの3ヶ月間の売上高は、前年同期の3155億円から9.3%増加し、3448億円となった。 12月31日までの通期について、同社は株主に帰属する利益を611億円、1株当たり基本利益を161.21円、売上高を1兆3110億円と見込んでいる。 大塚製薬は、今年度の中間配当と期末配当をそれぞれ1株当たり50円と45円とする予定で、これは前年同期の配当額を上回る。
Related Articles
Asia
Atlas Arteria Says IFM Global's Takeover Offer Will Not Open Before May 11
Atlas Arteria (ASX:ALX) said an unsolicited takeover offer from IFM Global Infrastructure Fund will not open before May 11 at the earliest, and once it does, it will remain open for at least a month, according to a Friday filing with the Australian bourse.IFM owns about 35% of the issued shares of Atlas Arteria and has proposed to acquire the remaining interest at AU$4.75 per share in cash. The price may increase to AU$5.10 per share if IFM obtains at least a 45% interest before the offer closes.In a letter to its shareholders, Atlas Arteria warned that the proposal is subject to many conditions that might not be satisfied. It also cautioned that shareholders would receive the lower price if IFM's relevant interest threshold is not achieved prior to closing.Atlas Arteria has created an independent board committee to evaluate the proposal and will provide a recommendation to shareholders in due course, it said.
$ASX:ALX
US Markets
Wuliangye Yibin's First-Quarter 2026 Profit Nearly Tops Full-Year 2025 Figure
Wuliangye Yibin's (SHE:000858) first-quarter attributable profit surged 83% from the year-ago period on higher revenue despite surging sales costs.The baijiu distillery logged an attributable profit of 8.06 billion yuan during the three months through March 31, higher than 4.42 billion yuan recorded in the year-ago period, according to an after-hours filing on Thursday.The company also attributed the higher profit to a lower base in the year-ago period.First-quarter profit nearly topped the profit recorded for the whole of 2025 at 8.95 billion yuan, down 72% from 31.9 billion yuan in the year-ago period.Singapore-based investment intelligence platform Smartkarma estimated a net profit of 11.16 billion yuan.Q1 earnings per share jumped 83% to 2.0772 yuan from 1.1378 yuan.Wuliangye Yibin's revenue grew 34% to 22.8 billion yuan from 17.1 billion yuan in the prior-year period.Total operating costs jumped 11% to 12.2 billion yuan from nearly 11 billion yuan a year earlier, the baijiu manufacturer said in its filing.Sales costs surged 145% to 3.67 billion yuan from 1.49 billion yuan.The jump could mean Wuliangye is either actively increasing channel development investment and brand promotion or subsidizing dealers facing pricing pressures, Futu said in its digital platform, Futubull.Net cash flow from operating activities turned to a negative 2.54 billion yuan from positive inflows of 15.8 billion yuan in the year-ago period.A high volume of collected bills due to market changes caused the negative cash flow, Futu said, citing Wuliangye.Cash and cash equivalents stayed at 1.3 times higher than the annual revenue, Futu said.Meanwhile, the wine maker plans to repurchase between 8 billion yuan and 10 billion yuan of shares for up to 153.59 yuan apiece, according to a separate disclosure.
$SHE:000858
Asia
SJ Semiconductor Q1 Profit Up 52%
SJ Semiconductor (SHA:688820) posted first-quarter attributable net profit of 191.3 million yuan, up 52% from 126.3 million yuan the previous year.Earnings per share rose to 0.12 yuan from 0.08 yuan, according to a Thursday filing with the Shanghai bourse.The semiconductor wafer manufacturer's operating revenue climbed 13% year over year to 1.70 billion yuan from 1.50 billion yuan.
$SHA:688820